This study conducted a Phase I clinical trial in 9 patients with mild-to-moderate Alzheimer’s disease dementia to evaluate the safety and dose-limiting toxicity of 3 repeated intracerebroventricular injections of human #umbilical #CordBlood–derived MSCs.
New article: Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial https://t.co/jcEtCcPSLT #alzheimers #neurology https://t.co/xwwP2GInAY
Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer’s disease dementia: a phase I clinical trial https://t.co/6W5yMH0Gx9 https://t.co/glmnc2bWC8